Heterocyclic GLP-1 agonists
US12291529B2 · kind B2 · utility
0Cited by
2References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2024 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Jul 2, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates generally to GLP-1 agonists and pharmaceutical compositions comprising the same, as well as methods for treating a GLP-1 associated disease, disorder, or condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.